Susan Hasty, Publisher
Table of Contents . . . August 18th, 2010Non-Subscriber - Summaries Only
Tuberculosis - A breakthrough in tuberculosis research
Alpha Virus - Alphavirus-based vaccine may slow some cancers
Bladder Cancer - Celldex Reports Second Quarter 2010 Financial Results
Novavax, Inc. - NOVAVAX Elects Richard H. Douglas to its Board of Directors
Pfenex Inc. - Pfenex Inc. Awarded Contract With the United States Federal Government Potentially Totaling Up to $18.8 Million to Develop a Robust Pfenex Expression Technology Based Process for the Production of Bulk Recombinant Protective Antigen rPA From Anthrax.
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.